Crossover Study From Macitentan or Bosentan Over to Ambrisentan

NCT02885012 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Study ending due to lack of enrollment.

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: Ambrisentan

Sponsor

Medical University of South Carolina

Collaborators

[object Object]